Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Tokyo  >  Asahi Kasei Corp    3407   JP3111200006

News SummaryMost relevantAll newsSector news 

Asahi Kasei Corp. : Construction of new acetonitrile plant in Korea

share with twitter share with LinkedIn share with facebook
share via e-mail
03/06/2012 | 04:35am CEST

Asahi Kasei Chemicals Corp.

Asahi Kasei Chemicals has finalized a decision to construct a new acetonitrile plant in Korea. The plant will have a production capacity of 11,000 tons per year, and start-up is scheduled for January 2014. Having a second production base for acetonitrile, in addition to its Japanese base, will enable Asahi Kasei Chemicals to assure a reliable supply of acetonitrile as demand continues to grow rapidly worldwide.

Acetonitrile is produced by refining the crude acetonitrile obtained as a byproduct of acrylonitrile (AN). It is mainly used as a solvent in the manufacture of pharmaceuticals, with other notable uses including as analytical reagent and in the field of agrichemicals. With an acetonitrile plant in Kawasaki, Kanagawa, Japan, having a production capacity of 14,000 tons per year, Asahi Kasei Chemicals is a major supplier to markets in Asia and Europe as well as Japan. Strong growth in demand for acetonitrile is forecasted, particularly for use in the field of pharmaceutical manufacture. Asahi Kasei Chemicals had therefore been examining how best to increase production capacity and ensure reliable supply as markets continue to grow.

A decision was made to construct a new acetonitrile plant at Tong Suh Petrochemical Corp., Ltd., an Asahi Kasei Group company in Korea, which is currently constructing a new AN plant in Ulsan with startup scheduled for January 2013. The acetonitrile plant in Korea will utilize crude acetonitrile byproduct from the AN plants in Korea.

Having two production bases for acetonitrile, in Japan and Korea, will enable Asahi Kasei Chemicals to provide reliable supply to meet growing demand in the pharmaceutical industry especially in India and China.
share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on ASAHI KASEI CORP
10/20 ASAHI KASEI : Patent Issued for Position Detection Apparatus (USPTO 9467603)
10/19 GLOBAL AND CHINA METHYL METHACRYLATE : Mitsubishi Rayon, Evonik, Dow, Sumitomo C..
10/07 ASAHI KASEI : Home Order Trends – September 2016
10/05 ASAHI KASEI : Daramic Assigned Patent
09/29 ASAHI KASEI : Patent Issued for Current Sensor Substrate and Current Sensor (USP..
09/29 ASAHI KASEI : Researchers Submit Patent Application, "Methacrylic Resin Composit..
09/29 ASAHI KASEI : Patent Issued for Digital-Analog Converter and Digital-Analog Conv..
09/28 ASAHI KASEI : Celgard Assigned Patent
09/28 ASAHI KASEI : Approval for manufacture and sale of Reclast® in Japan
09/28 ASAHI KASEI CORP : ex-dividend day for interim dividend
More news
Sector news : Commodity Chemicals - NEC
10/19DJAKZO NOBEL : Posts 1% Rise in 3Q Adjusted Ebit, Beating Expectations
10/18 LG CHEM : sees GM selling over 30,000 Bolt electric vehicles next year
10/08 PETROLEO BRASILEIRO PETROBRAS : Odebrecht patriarch leads Brazil plea deal talks..
10/07DJPPG INDUSTRIES : Profit to Miss Street View
10/07DJPPG INDUSTRIES : Third-Quarter Profit to Miss Wall Street View
More sector news : Commodity Chemicals - NEC
News from SeekingAlpha
07/05 A YEAR OF SCANDAL : The Beginning Of The End Of Cronyism In Japan?
03/31 Array Bio licenses TrkA inhibitors to Asahi Kasei Pharma in Asia for up to $7..
2015 Polypore merges with Asahi Kasei
2015 REGENERATIVE MEDICINE IN JAPAN : CJ Partners' Colin Lee Novick
2015 3M Co. Announces $1B Deal To Acquire Polypore Unit
Financials ( JPY)
Sales 2017 1 880 933 M
EBIT 2017 -
Net income 2017 90 952 M
Debt 2017 250 989 M
Yield 2017 2,32%
P/E ratio 2017 13,34
P/E ratio 2018 12,30
EV / Sales 2017 0,78x
EV / Sales 2018 0,74x
Capitalization 1 222 661 M
More Financials
Duration : Period :
Asahi Kasei Corp Technical Analysis Chart | 3407 | JP3111200006 | 4-Traders
Full-screen chart
Technical analysis trends ASAHI KASEI CORP
Short TermMid-TermLong Term
Technical analysis
Income Statement Evolution
More Financials
Mean consensus OUTPERFORM
Number of Analysts 14
Average target price 873  JPY
Spread / Average Target 0,09%
Consensus details
EPS Revisions
More Estimates Revisions
Hideki Kobori President & Representative Director
Ichiro Itoh Chairman
Norio Ichino Independent Director
Masafumi Nakao Director
Yuji Kobayashi Representative Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ASAHI KASEI CORP11.08%11 773
AIR LIQUIDE-7.61%39 470
PRAXAIR, INC.17.07%34 194
SHIN-ETSU CHEMICAL CO ..15.60%31 264
More Results